Long-term augmentation therapy with Alpha-1 antitrypsin in an MZ-AAT severe persistent asthma

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 69, Issue 4, 2008, Pages 178-182

  Blanco, Ignacio Blanco ^a   Canto, H ^a   Flores J ^a   Camblor, C ^a   Carcaba V ^a   de Serres, F J ^b   Janciauskiene, S ^c   Bustillo, E F ^d  

^a Valle del Nalon Hospital   (Spain)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Department of Hematology   (Spain)

Author keywords

Alpha 1 Antitrypsin deficiency augmentation therapy; Alpha 1 Antitrypsin phenotypes; Augmentation therapy with Alpha I antitrypsin; Bronchial asthma; SerpinA1

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARBIMAZOLE; CORTICOSTEROID; GLUCOCORTICOID; LEVOTHYROXINE; MONTELUKAST; PREDNISONE; RADIOISOTOPE; THEOPHYLLINE;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; AUGMENTATION THERAPY; BONE DENSITY; CASE REPORT; CAUCASIAN; CONSERVATIVE TREATMENT; DISEASE CONTROL; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LUNG FUNCTION; MENTAL HEALTH; MODERATE PERSISTENT ASTHMA; MUSCLE MASS; OBESITY; PHENOTYPE; PHYSICAL CAPACITY; PRESCRIPTION; SEVERE PERSISTENT ASTHMA; SIDE EFFECT; SOCIAL LIFE;

EID: 62549122022     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2008.380     Document Type: Article

References (14)

1. de Serres FJ, Blanco I, Fernández-Bustillo E. PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data. Monaldi Arch Chest Dis 2007; 67: 184-208.
2. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900.
3. Janciauskiene SM, Stevens T, Blanco I. New insights into the biology of ocl-antitrypsin and its role in chronic obstructive pulmonary disease. Curr Respir Med Rev 2007; 3: 147-158.
4. Blanco I., Canto H., de Series F.J., Bustillo E.F., Rodríguez M.C. Alpha-1-antitrypsin replacement therapy efficiently controls fibromyalgia symptoms in two PI ZZ alpha-1-antitrypsin deficiency patients. J Rheumatol 2004; 31: 2082-2085.
5. Heresi GA, Stoller JK. Augmentation therapy in alpha-1 antitrypsin deficiency. Expert Opin Biol Ther 2008; 8: 515-526.
6. Eden E, Strange C, Holladay B, Xie L. Asthma and allergy in alpha-1 antitrypsin deficiency. Respir Med 2006; 100: 1384-1391.
7. Hersh CP, Dahl M, Ly NP, Berkey CS, Nordestgaard BG, Silverman EK. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 2004; 59: 843-849.
8. Vignola AM, Bonanno A, Mirabella A, et al. Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med 1998; 157: 505-11.
9. Hiraguchi Y, Nagao M, Hosoki K, Tokuda R, Fujisawa T. Neutrophil Proteases Activate Eosinophil Function in vitro. Int Arch Allergy Immunol 2008; 146 Suppl 1: 16-21.
10. Huang CD, Chen HH, Wang CH, et al. Human neutrophil-derived elastase induces airway smooth muscle cell proliferation. Life Sci 2004; 74: 2479-2492.
11. Lee KY, Ho SC, Lin HC, et al. Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway. Am J Respir Cell Mol Biol 2006; 35: 407-414
12. Forteza R, Botvinnikova Y, Ahmed A, et al. The interaction of alpha 1-proteinase inhibitor and tissue kallikrein in controlling allergic ovine airway hyperresponsiveness. Am J Respir Crit Care Med 1996; 154: 36-42.
13. Scuri M, Botvinnikova Y, Lauredo IT, Abraham WM. Recombinant alpha 1-proteinase inhibitor blocks antigen- and mediator-induced airway responses in sheep. J Appl Physiol 2002; 93: 1900-1906.
14. Chughtai B, O'Riordan TG. Potential role of inhibitors of neutrophil elastase in treating diseases of the airway. J Aerosol Med 2004; 17: 289-298.